tm
Seeing Is Believing
tm
Seeing Is Believing
Landos Biopharma's activity chart (see below) currently has 13 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.5% with an average time for these price targets to be met of 109.9 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 01-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2021
$20.42
$-2.51 (-10.95%)
$500
2 years 6 months 4 days ago
(01-Apr-2024)
0/2 (0%)
$-1.18 (-5.46%)
Hold Since 06-Jan-2023
$1
$-21.93 (-95.64%)
$14
3 years 8 months 29 days ago
(06-Jan-2023)
1/4 (25%)
$-3.05 (-75.31%)
713
Hold Since 12-Aug-2022
3 years 10 months 24 days ago
(11-Nov-2022)
0/2 (0%)
$53.4 (50.09%)
Buy Since 01-Mar-2021
$9
4 years 1 months 23 days ago
(12-Aug-2022)
2/2 (100%)
$-8.7 (-49.15%)
181
Hold Since 01-Mar-2021
$70
$47.07 (205.28%)
$170
4 years 9 months 2 days ago
(03-Jan-2022)
0/2 (0%)
$17.8 (34.10%)
What is LABP (Landos Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on LABP (Landos Biopharma)?
Which analyst has the most public recommendations on LABP (Landos Biopharma)?
Which analyst is the currently most bullish on LABP (Landos Biopharma)?
Which analyst is the currently most reserved on LABP (Landos Biopharma)?
